A detailed history of Bank Of America Corp transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 149,998 shares of MEDP stock, worth $52.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
149,998
Previous 143,728 4.36%
Holding current value
$52.7 Million
Previous $58.1 Million 6.35%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$372.0 - $424.34 $2.33 Million - $2.66 Million
6,270 Added 4.36%
149,998 $61.8 Million
Q1 2024

May 15, 2024

BUY
$284.87 - $413.31 $2.19 Million - $3.17 Million
7,678 Added 5.64%
143,728 $58.1 Million
Q4 2023

Feb 14, 2024

SELL
$227.52 - $312.68 $10.8 Million - $14.9 Million
-47,537 Reduced 25.89%
136,050 $41.7 Million
Q2 2023

Aug 14, 2023

BUY
$187.26 - $240.17 $2.8 Million - $3.59 Million
14,945 Added 8.86%
183,587 $44.1 Million
Q1 2023

May 12, 2023

BUY
$174.31 - $239.52 $954,695 - $1.31 Million
5,477 Added 3.36%
168,642 $31.7 Million
Q4 2022

Feb 10, 2023

BUY
$153.06 - $226.57 $162,243 - $240,164
1,060 Added 0.65%
163,165 $34.7 Million
Q3 2022

Nov 14, 2022

BUY
$145.13 - $182.49 $760,481 - $956,247
5,240 Added 3.34%
162,105 $25.5 Million
Q2 2022

Aug 12, 2022

BUY
$130.2 - $168.03 $226,157 - $291,868
1,737 Added 1.12%
156,865 $23.5 Million
Q1 2022

May 16, 2022

BUY
$138.87 - $214.31 $543,537 - $838,809
3,914 Added 2.59%
155,128 $25.4 Million
Q4 2021

Feb 08, 2022

SELL
$182.74 - $227.9 $1.55 Million - $1.93 Million
-8,481 Reduced 5.31%
151,214 $32.9 Million
Q3 2021

Nov 15, 2021

BUY
$170.18 - $198.21 $4.52 Million - $5.27 Million
26,574 Added 19.96%
159,695 $30.2 Million
Q2 2021

Sep 13, 2021

BUY
$158.62 - $194.3 $21.1 Million - $25.9 Million
133,121 New
133,121 $23.5 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.9B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.